Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02664077
Title A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer (ARGO)
Acronym ARGO
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors NSABP Foundation Inc
Age Groups: adult
Covered Countries USA

No variant requirements are available.